EPOCH Chemotherapy and Bortezomib for Associated T-Cell Leukemia Lymphoma - Related Studies

EPOCH Chemotherapy and Bortezomib for Associated T-Cell Leukemia Lymphoma (ATLL)

This study is currently recruiting participants.

Verified December 2012 by Washington University School of Medicine

Study NCT01000285 Information provided by Washington University School of Medicine

First Received on October 19, 2009. Last Updated on December 20, 2012 History of Changes

Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:

Conditions listed in this trial

Additional conditions recognized in this trial

Leukemia
Leukemia, T-Cell
Lymphoma

More general conditions related to this trial

Additional drug interventions recognized in this trial

Bortezomib
Cyclophosphamide
Doxorubicin
Integrase Inhibitors
Prednisone
Vincristine

More general drug interventions related to this trial

Sponsors listed in this trial